J&J News - Facebook
J&J News. 55,519 likes · 8,542 talking about this. J&J News brings you all the facts.
Latest news - Johnson & Johnson
Oct 10, 2024 · Justin and Colin Farlow share how their next-generation cell and gene therapies are helping in its quest to get in front of cancer. A collection of stories that highlight the way Johnson & Johnson is making an impact in the lives of its consumers, and the latest press releases from the company.
J&J plans to split into two companies, separating consumer ... - CNBC
Nov 12, 2021 · Health-care conglomerate Johnson & Johnson announced plans Friday to split its consumer products business from its pharmaceutical and medical device operations, creating …
J&J sues HRSA for blocking controversial 340B rebate plan
5 days ago · J&J had floated the rebate plan in August and outlined an Oct. 15 implementation date. It would apply to purchases of two products, Stelara and Xarelto, by disproportionate share hospitals ...
J&J to pump another $13B into its MedTech ... - Associated Press News
Apr 5, 2024 · Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries. The health care giant said Friday that it will spend $335 in cash for each share of Shockwave. The total deal value includes cash acquired.
J&J to acquire Ambrx Biopharma, a cancer drug developer, for $2B
Jan 8, 2024 · Johnson & Johnson said it will acquire Ambrx Biopharma for $2 billion, picking up a drugmaker specializing in one of the hottest areas of cancer treatment. The deal, which was …
The battle over J&J’s bankruptcy plan to end talc lawsuits
Jul 8, 2024 · After being rebuffed twice by federal courts, the $350 billion healthcare giant is attempting again to end the litigation in a so-called “Texas two-step” bankruptcy. The maneuver involves...
‘Reassuring’ data suggests the J&J vaccine may still have a role to ...
Mar 20, 2022 · The US public and even some health experts may have underestimated the Covid-19 vaccine made by Janssen, a division of Johnson & Johnson, new data shows. And there’s emerging evidence that it...
J&J beats Wall St estimates on strong drug sales ahead of Stelara ...
Jul 17, 2024 · Johnson & Johnson beat estimates for second-quarter profit and revenue on Wednesday, driven by strong sales of its drugs, including cancer treatment Darzalex and blockbuster psoriasis drug Stelara.
J&J advances $6.48 billion settlement of talc cancer lawsuits
NEW YORK, May 1 (Reuters) - Johnson & Johnson (JNJ.N) said on Wednesday it is moving forward with a $6.48 billion proposed settlement of tens of thousands of lawsuits alleging that its baby...
- Some results have been removed